drugset / Trial / NCT07177456

Study on Safety and Efficacy of UCB-MNCs for Radiation-induced Lung Injury

NCT07177456 ↗

Phase 0 Not yet recruiting 10 enrolled Zhejiang Cancer Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study aims to evaluate the safety and efficacy of the umbilical cord blood mononuclear cells (UCB-MNCs) therapy for radiation-induced lung injuryr (RILI) by observing factors related to the therapeutic effect and adverse reactions of UCB-MNCs in treating RILI .

Timeline

Start
2025-10-01
Primary completion
2026-10-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject UCB-MNCs Cell therapy 3e+08 cells Intravenous